Skip to main content
PODD logo

Insulet Corporation

PODDNASDAQHealthcareMedical Devices

$141.10Today:- (-)1Y −56.44%

As of Oct 16, 2026 close

Market cap
$9.63B
P/E (TTM)
25.66
Forward P/E
16.34
Dividend yield
-
52-week range
$126.40$354.88
Volume (live)
-
Avg. volume (3M)
1.61M

Insulet (PODD) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Insulet generated $569.30M of operating cash flow and spent $191.60M on capital expenditures. That left free cash flow of $377.70M, up 23.7% from $305.30M a year earlier, or 13.9% of revenue. It repurchased $59.60M of its own shares.

Insulet Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Insulet Corporation (PODD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income247.10418.30206.304.6016.806.8011.603.30-26.80
Depreciation & Amortization90.4080.8072.8063.2057.4055.4027.9015.6013.90
Deferred Income Tax62.20-136.900.00-1.0045.503.300.000.000.00
Stock Based Compensation62.7069.3048.4040.9034.4035.9028.7037.5031.90
Change in Working Capital-23.10-17.00-190.60-2.50-263.60-63.40-19.70-52.801.70
Change in Accounts Receivable-140.20-10.40-154.20-51.80-71.30-15.60-10.90-14.60-26.30
Change in Inventory-10.60-32.40-53.60-49.10-154.40-50.50-30.20-38.801.70
Change in Accounts Payable49.202.20-11.00-2.40-15.607.1025.60-5.4027.30
Change in Other Working Capital78.50-21.90-42.109.6041.40-4.40-4.206.00-1.00
Other Operating Activities130.00-121.008.909.6041.4046.0049.9032.3020.60
Net Cash from Operating Activities569.30430.20145.70119.00-68.1084.0098.4035.9041.30
Investing Activities
Capital Expenditures-191.60-124.90-75.60-157.30-122.70-166.50-170.90-162.35-77.23
Acquisitions0.000.00-3.00-26.000.00166.500.000.000.00
Purchases of Investments0.00-12.20-7.20-7.800.00-37.90-150.60-191.40-298.00
Sales/Maturities of Investments0.00-9.10-33.6040.0040.00218.40247.90169.30164.40
Other Investing Activities-31.100.00-3.00-40.000.00-166.50-170.90-0.050.03
Net Cash from Investing Activities-222.70-146.20-119.40-191.10-82.7014.00-73.60-184.50-210.80
Financing Activities
Debt Repayment-708.10-158.60-27.00-39.80-483.20126.60116.60-6.70292.80
Common Stock Issued33.9020.1026.9016.3023.50477.50-34.5015.8215.80
Common Stock Repurchased-59.60-7.60-13.200.000.000.000.000.000.00
Other Financing Activities138.500.10-0.30-16.80-32.201.40-8.60-17.82-4.10
Net Cash from Financing Activities-595.30-28.00-13.60-40.3040.70605.5073.50-8.70304.50
Summary
Effect of Forex Changes on Cash11.50-6.801.80-4.30-5.504.801.50-1.400.40
Net Change in Cash-237.30249.2014.40-116.70-110.10708.3099.80-158.70135.40
Cash at Beginning of Period953.40704.20689.70806.40922.00213.70113.90272.60137.20
Cash at End of Period716.10953.40704.20689.70806.40922.00213.70113.90272.60
Free Cash Flow377.70305.3070.10-38.30-190.80-82.50-72.50-126.46-36.02
Supplemental Disclosures
Interest Paid50.8047.1049.9034.2021.50----
Income Taxes Paid38.5020.608.105.507.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Insulet Cash Flow

What is Insulet's free cash flow?

Insulet generated free cash flow of $377.70M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $569.30M minus $191.60M of capital expenditures. That was up 23.7% from $305.30M a year earlier. Free cash flow equaled 13.9% of revenue.

How much does Insulet spend on capital expenditures?

Insulet spent $191.60M on capital expenditures in fiscal 2025, compared with $124.90M a year earlier. That equals 33.7% of operating cash flow.

Does Insulet pay dividends or buy back shares?

Yes. In fiscal 2025 Insulet returned $59.60M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition